To shed light on IgA we compared IgG (~98%) containing IVIG (IgG Next Generation, Biotest AG), as well as IgG (~56%), IgA (~21%), and IgM (~23%) containing trimodulin (trimodulin, Biotest AG), regarding their anti-inflammatory effects in our COVID-19 cell model. This evidence concerns the gene CD79A and COVID-19.